PRRT2 and metabolic syndrome: Considering the central role of dyslipidemia in the activation of polyol, AGE, PKC and hexosamine pathways involved in the pathogenesis of diabetic neuropathy, normalization of the lipid profile may reduce lipotoxicity in the vasa nervorum and Schwann cells, diminishing oxidative stress and intraneural inflammation [9].